Home
Company
- Back
- Company
- Team
- Corporate deck
- History
- Investors
CCS1477
- Back
- CCS1477
- Publications
- Translation
- Differentiation
Clinical
Updates
- Back
- Updates
- Press releases
- Blogs
Contact

Blogs

Short information articles

on our science and its application

Jan 15, 2020
Targeting p300/CBP: A New Approach to Treating Cancer

CCS1477
Translation
Clinical trials
Latest news

About CellCentric

CellCentric is a clinical stage biotechnology company focused on the development of the novel drug CCS1477 for prostate (CRPC) and other cancers.

Quick links

Company
Team
CCS1477
Clinical
Translation
Updates
Publications

Follow us

Follow us and stay up to date with our latest news, events and scientific posters.

Follow us on Twitter

Copyright © 2020 Cellcentric

Contact us

Designed and built by Onespacemedia